Randomized placebo-controlled trial of losartan for pediatric NAFLD.
Vos, MB; Van Natta, ML; Blondet, NM; Dasarathy, S; Fishbein, M; Hertel, P; Jain, AK; Karpen, S; Lavine, JE; Mohammad, S; et al.
Hepatology.
2022;
76:429-444.
Mycophenolate mofetil use is associated with reduced incidence of food allergy in liver transplanted children.
Ley, SL; Kidwell, KM; Van Dyk, TR; Orkin, S; Odar Stough, C; Howarth, T; Goetz, AR; Xanthakos, SA; Bramlage, K; Mouzaki, M; et al.
Journal of Pediatric Gastroenterology and Nutrition.
2022;
75:138-144.
Clinically Meaningful Body Mass Index Change Impacts Pediatric Nonalcoholic Fatty Liver Disease.
Khurana, T; Klepper, C; Fei, L; Sun, Q; Bramlage, K; Arce-Clachar, AC; Xanthakos, S; Mouzaki, M.
Journal of Pediatrics.
2022.
Insight Into the Adolescent Patient Experience With Nonalcoholic Fatty Liver Disease.
Ley, SL; Kidwell, KM; Van Dyk, TR; Orkin, S; Odar Stough, C; Howarth, T; Goetz, AR; Xanthakos, SA; Bramlage, K; Mouzaki, M; et al.
Journal of Pediatric Gastroenterology and Nutrition.
2022;
75:88-96.
Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children.
Rosenthal, SB; Nasamran, C; Behling, CA; Angeles, JE; Harlow, KE; Mollewston, JP; Ugalde-Nicalo, P; Xanthankos, SA; Yates, K; Schork, NJ; et al.
Hepatology.
2022.
Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
Newton, KP; Wilson, LA; Crimmins, NA; Fishbein, MH; Molleston, JP; Xanthakos, SA; Behling, C; Schwimmer, JB; Garner, D; Hertel, P; et al.
Clinical Gastroenterology and Hepatology.
2022.
Nonalcoholic Fatty Liver Disease in Young Children with Obesity.
Klepper, C; Crimmins, NA; Orkin, S; Sun, Q; Fei, L; Xanthakos, S; Mouzaki, M.
Childhood Obesity.
2022.
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
Cusi, K; Isaacs, S; Barb, D; Basu, R; Caprio, S; Garvey, WT; Kashyap, S; Mechanick, JI; Mouzaki, M; Nadolsky, K; et al.
Endocrine Practice.
2022;
28:528-562.
BMI Metrics Are Poor Predictors of Pediatric Nonalcoholic Fatty Liver Disease Severity.
Klepper, CM; Khurana, T; Sun, Q; Fei, L; Crimmins, NA; Siegel, R; Mouzaki, M.
Childhood Obesity.
2022.
Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children With Non-Alcoholic Fatty Liver Disease.
Yodoshi, T; Orkin, S; Trout, AT; Arce-Clachar, AC; Bramlage, K; Liu, C; Fei, L; Dillman, JR; Xanthakos, SA; Mouzaki, M.
Journal of Pediatric Gastroenterology and Nutrition.
2022;
74:495-502.